Vantis Vascular develops technology for vascular interventions targeting complex arteries.
Vantis Vascular has raised $18.6M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in July 2026.
Vantis Vascular's investors include Angelini Ventures, Bayern Kapital, Twip Impact Ventures.
Vantis Vascular is headquartered in San Jose, United States.
Vantis Vascular develops technology for vascular interventions targeting complex arteries.
Vantis Vascular is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Vantis Vascular — Funding & Investors." VCBacked, July 10, 2026, https://www.vcbacked.co/company/vantis-vascular. Accessed November 12, 2026.
VCBacked. (2026). Vantis Vascular — Funding & Investors. Retrieved November 12, 2026, from https://www.vcbacked.co/company/vantis-vascular
{{cite web |title=Vantis Vascular — Funding & Investors |url=https://www.vcbacked.co/company/vantis-vascular |website=VCBacked |access-date=November 12, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Vantis Vascular? Request a listing update